Cost and Time Efficiencies
InSymbiosis has implemented an extremely innovative model allowing us to significantly reduce drug development budgets and reduce program timelines. The key features to our model are:
- Skilled planning of drug development programs, focusing on the critical path and eliminating unnecessary experiments or steps
- Leveraging our outsourcing volume to secure more competitive prices and schedules from our vendors
- Leveraging a variety of novel cost reduction strategies and programs in Canada and Europe
By combining the tools above, InSymbiosis provides a new deal making paradigm never seen before in the CRO industry allowing us to collaborate under both fee for service and risk-shared models.